VANCOUVER, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical, Inc. (CSE:BTH)
(OTCQB:BTHCF) (the “Company” or “Breathtec”) - at the request of the Investment Industry
Regulatory Organization of Canada, Breathtec confirms that the Company management is unaware of any material change or
event with respect to the Company’s operation or activities that would account for the recent increase in market activity and
price increase.
ABOUT BREATHTEC BIOMEDICAL INC. (CSE:BTH) (OTCQB:BTHCF)
Breathtec Biomedical, Inc. (“Breathtec”) was formed to propel innovative research in the area of airborne
analysis as a medical screening tool. Our efforts are aimed at leading the development of commercially viable methods for the early
screening of certain pathogens. Our primary avenue of investigation is focused on innovation and advances in the field of
specialized mass spectrometry. For more information: www.breathtecbiomedical.com.
ON BEHALF OF THE BOARD
“Michael Sadhra”
Chief Financial Officer & Director
CONTACT:
Alfred Wong
Tel: 604 398 8840 ext 700
info@breathtechbiomedical.com
investors@breathtecbiomedical.com
www.breathtecbiomedical.com
CAUTIONARY DISCLAIMER STATEMENT: No Securities Exchange has reviewed nor accepts responsibility for the
adequacy or accuracy of the content of this news release. This news release contains forward-looking statements
relating to product development, licensing, commercialization and regulatory compliance issues and other statements that are not
historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects”
and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking
statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and
actual results and future events could differ materially from those anticipated in such statements. Important factors that could
cause actual results to differ materially from the Company’s expectations include the failure to satisfy the conditions of the
relevant securities exchange(s) and other risks detailed from time to time in the filings made by the Company with securities
regulations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be
incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous
known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is
cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by
management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking
statements contained in this news release are made as of the date of this news release and the Company will update or revise
publicly any of the included forward-looking statements as expressly required by applicable law.
